Skip to main content

Table 4 Endocrinological investigation: GHRP-2 stimulation test in January 2018 (day 8 after admission)

From: Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature

 

Time (min)

0

15

30

45

60

Adrenocorticotropic hormone (pg/ml)

1.9

2.3

1.9

1.9

3.2

Cortisol (μg/dl)

< 0.2

< 0.2

< 0.2

< 0.2

< 0.2

Growth hormone (ng/ml)

3.73

18.02

29.63

32.98

26.21

  1. Growth hormone-releasing peptide (GHRP)-2 (100 μg) was intravenously administered in the morning (9 a.m.)